2nd and 3rd-generation GPC3-targeting CAR-T (GPC3-CAR-T) possess activity against HCC cell lines (HepG2, Huh-7) in vitro and in vivo [63,67,68]. Here, GPC3 is linked to hepatocellular carcinoma.